About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Artificial Intelligence - SARS-CoV-2 (COVID-19) Risk Evaluation

Artificial Intelligence - SARS-CoV-2 (COVID-19) Risk Evaluation

NCT04834934·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

IRCCS San Raffaele

With

Regione Lombardia
Orobix Srl
Microsoft Corporation
ASST Bergamo Est
Centro Cardiologico Monzino
NVIDIA Corporation
PORINI Srl

Age

18–100

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

confirmed SARS-CoV-2 infection with RT-PCR
non contrast chest CT scan performed within 72 hours after admission to the emergency department

You may not be if

age \< 18 ys

The record

StatusCompleted

PhaseNo phase

Taking part2,000

StartedFeb 2020

UpdatedMay 1, 2025

Conditions

Where1

IRCCS San Raffaele
Milan, Italy